1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Enhancement characteristics of intramedullary spinal cord metastases and primary masses (per-lesion basis)
Intramedullary Spinal Cord Metastases (n = 64) Primary Spinal Cord Masses (n = 64) Ependymoma (n = 21) Astrocytoma (n = 21) Hemangioblastoma (n = 11) Ganglioglioma (n = 5) Cavernous Malformation (n = 6) No enhancement 1 (2%) 10 (16%) 0 6 (29%) 0 1 (20%) 3 (50%) Rim sign 21 (33%) 2 (3%) 0 0 2 (18%) 0 0 Flame sign 19 (30%) 2 (3%) 1 (5%) 1 (5%) 0 0 0 Rim without flame sign 9 (14%) 2 (3%) 0 0 2 (18%) 0 0 Flame without rim sign 7 (11%) 2 (3%) 1 (5%) 1 (5%) 0 0 0 Only rim or flame signa 16 (25%) 4 (6%) 1 (5%) 1 (5%) 2 (18%) 0 0 Both rim and flame signs 12 (19%) 0 0 0 0 0 0 At least rim or flame signb 28 (44%) 4 (6%) 1 (5%) 1 (5%) 2 (18%) 0 0